Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Goldman

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Pediatrics|May 23, 2001
Serologic evidence for Cryptococcus neoformans infection in early childhoodD L Goldman, H Khine, J Abadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive functionE A Neuwelt, D L Goldman, S A Dahlborg, et al.
Rhode Island Medicine|April 1, 1994
Activity reduction and disability among persons with diabetesD L Goldman, J P Fulton, D K Perry, et al.
Clinical and Vaccine Immunology : CVI|October 26, 2007
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipientsD C Saha, D L Goldman, X Shao, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studiesA Casadevall, W Cleare, M Feldmesser, et al.
Medical Mycology|February 24, 2001
Fungal morphogenesis and virulenceG San-Blas, L R Travassos, B C Fries, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Pediatrics|May 23, 2001
Serologic evidence for Cryptococcus neoformans infection in early childhoodD L Goldman, H Khine, J Abadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive functionE A Neuwelt, D L Goldman, S A Dahlborg, et al.
Rhode Island Medicine|April 1, 1994
Activity reduction and disability among persons with diabetesD L Goldman, J P Fulton, D K Perry, et al.
Clinical and Vaccine Immunology : CVI|October 26, 2007
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipientsD C Saha, D L Goldman, X Shao, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studiesA Casadevall, W Cleare, M Feldmesser, et al.
Medical Mycology|February 24, 2001
Fungal morphogenesis and virulenceG San-Blas, L R Travassos, B C Fries, et al.
Pageof 4